Research & IP · United Kingdom

GSK

One of the world's largest vaccine businesses (Shingrix, Arexvy, Bexsero, pandemic adjuvant AS03) and developer of novel antibiotics such as gepotidacin.

Headquarters
London, United Kingdom · Europe
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2000
Staff
68,629 (2024)
Ownership
Listed
Listing
LSE:GSK on Google Finance
Website
gsk.com
Relevance
Very high at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Design · listed #4 of 50

    One of the world's largest vaccine businesses (Shingrix, Arexvy, Bexsero, pandemic adjuvant AS03) and developer of novel antibiotics such as gepotidacin.

    Relevance: One of world’s largest vaccine businesses

    Source · en.wikipedia.org